project id: TCGA-CESC; case submitter id: TCGA-C5-A2LV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.0; age at index: 36; days to birth: -13447; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1967; age at diagnosis: 13447; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2234.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.8767123287671232; pack years smoked: 16.0; is ffpe: false; composition: Not Reported; days to collection: 3016; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-C5-A2LV-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;